Tolterodine, an Effective and Well Tolerated Treatment for Urge Incontinence and Other Overactive Bladder Symptoms
- 1 February 2000
- journal article
- Published by Springer Nature in Clinical Drug Investigation
- Vol. 19 (2) , 83-91
- https://doi.org/10.2165/00044011-200019020-00001
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- ONCE DAILY CONTROLLED VERSUS IMMEDIATE RELEASE OXYBUTYNIN CHLORIDE FOR URGE URINARY INCONTINENCEJournal of Urology, 1999
- Quality‐of‐life aspects of the overactive bladder and the effect of treatment with tolterodineBJU International, 1999
- Efficacy and safety of tolterodine in patients with detrusor instability: a dose‐ranging studyBritish Journal of Urology, 1998
- A medium term analysis of the subjective efficacy of treatment for women with detrusor instability and low bladder complianceBJOG: An International Journal of Obstetrics and Gynaecology, 1997
- Tolterodine – a new bladder-selective antimuscarinic agentEuropean Journal of Pharmacology, 1997
- Tolterodine-a new bladder selective muscarinic receptor antagonist: Preclinical pharmacological and clinical dataLife Sciences, 1997
- Urodynamic and other effects of tolterodine: A novel antimuscarinic drug for the treatment of detrusor overactivityNeurourology and Urodynamics, 1995
- Oxybutynin Chloride for Geriatric Urinary Dysfunction: a Double-blind Placebo-controlled StudyAge and Ageing, 1989
- Current Concepts in the Treatment of Disorders of MicturitionDrugs, 1988
- Placebo—the Drug of Choice in Female Motor Urge Incontinence?British Journal of Urology, 1983